Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2011-03-23 15:08:23
Reporting Period:
Filing Date:
Accepted Time:
2011-03-23 15:08:23
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
901219 Human Genome Sciences Inc HGSI Biological Products, (No Disgnostic Substances) (2836) 223178468
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1280044 Maxine Gowen 14200 Shady Grove Road
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-03-21 7,926 $27.29 23,663 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. This transaction was executed in multiple trades at prices ranging from $27.28 to $27.31. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.